[Federal Register Volume 73, Number 146 (Tuesday, July 29, 2008)]
[Notices]
[Pages 43945-43946]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-17336]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Agency Information Collection Activities Under Emergency Review 
by the Office of Management and Budget

    The Substance Abuse and Mental Health Services Administration 
(SAMHSA) has submitted the following request (see below) for emergency 
OMB review under the Paperwork Reduction Act (44 U.S.C. Chapter 35). 
OMB approval has been requested by August 8, 2008. A copy of the 
information collection plans may be obtained by calling the SAMHSA 
Reports Clearance Officer on (240) 276-1243.
    Title: Minority AIDS Initiative for Collaboration for Prevention 
and Treatment Improvement for American Indians and Alaska Natives at 
Risk for Substance Use and HIV/AID, (MIA) Rapid HIV Testing Clinical 
Information Form--NEW.
    OMB Number: 0930-New.
    Frequency: One-time-only
    Affected Public: Tribes, Non-Profit Tribal Organization and Urban 
Indian Health Centers.
    The Substance Abuse and Mental Health Services Administration's 
(SAMHSA) Center Substance Abuse Treatment (CSAT), is requesting an 
emergency OMB review and approval of the Minority AIDS Initiative for 
Collaboration for Prevention and Treatment Improvement for American 
Indians and Alaska Natives at Risk for Substance Use and HIV/AID, (MIA) 
Rapid HIV Testing Clinical Information Form. The MAI HIV Rapid Testing 
Clinical Information Form would allow SAMHSA/CSAT to collect essential 
clinical information that will be used for quality assurance, quality 
performance, and product monitoring on approximately 50,000 Rapid HIV 
Test Kits to be provided to American Indian and Alaska Native (AI/AN) 
communities at no cost to the recipient provider organizations. This 
Program is authorized under section 509 of the Public Health Service 
(PHs) Act [42 U.S.C. 290bb-2] .
    The purpose of the MAI is to increase HIV/Screening to American 
Indians and Alaska Natives at risk for substance use and thus HIV/AIDS 
in 13 States; build and or strengthen tribes, tribal organizations and 
urban Indian health centers capacity to provide HIV/AIDS education and 
prevention services to American Indians and Alaska Natives; reduce the 
stigma associated with HIV/AIDS screening through outreach and

[[Page 43946]]

education and increase the number of American Indians and Alaska 
Natives who know their HIV/AIDS status.
    The target population for the initiative is tribes, tribal 
organizations, and urban Indian organizations that reside in Alaska, 
Arizona, California, Florida, Michigan, Nevada, New Mexico, New York, 
North Carolina, Oklahoma, Texas, Utah and Washington who are at risk 
for substance use and HIV/AIDS. The selected states are those with the 
highest concentration of AI/AN population based on United States Census 
2000. It should be noted that 6 of these states (California, Florida, 
Nevada, North Carolina, and New York) are also designated Block Grant 
HIV State-aside states (reported 10 HIV cases per 100,000 to CDC). 
Additionally, the top five AI/AN AIDS Case states are--California, 
Oklahoma, Washington, Arizona and Alaska, which also are part of the 
target population.
    Given the history, SAMHSA could not have anticipated the need for 
the MAI Rapid HIV Testing Clinical Information Form earlier and is 
requesting an emergency OMB approval. Due to the six month shelf-life 
of the Rapid HIV Test Kits it is unlikely that SAMHSA will be able to 
distribute the kits and collect the essential clinical information 
prior to the expiration of the existing 20,000 Rapid HIV Test Kits 
without the emergency OMB approval. Emergency OMB approval will make 
available the immediate distribution of up to 50,000 no cost Rapid HIV 
Test kits to American Indian and Alaska Native communities. The MAI 
Rapid HIV Testing Clinical Information Form would support quality of 
care, provide minimum but adequate clinical and product monitoring, and 
provide appropriate safeguards against fraud, waste and abuse of 
Federal funds. SAMHSA's approach would avoid unnecessary delay in 
informing any person potentially adversely affected by a test kit 
recall or public health advisory.
    The following table is the estimated hour burden:

----------------------------------------------------------------------------------------------------------------
                                                                  Responses/                       Total burden
                    Number of respondents                         respondent      Burden hours        hours
----------------------------------------------------------------------------------------------------------------
50,000.......................................................               1             .167            8,350
----------------------------------------------------------------------------------------------------------------

    Written comments and recommendations concerning the proposed 
information collection should be sent within 30 Days of this notice to: 
John Kraemer, Human Resources and Housing Branch, Office of Management 
and Budget, New Executive Office Building, Room 10235, Washington, DC 
20503; due to potential delays in OMB's receipt and processing of mail 
sent through the U.S. Postal Service, respondents are encouraged to 
submit comments by fax to: 202-395-6974.

    Date: July 24, 2008.
Christine Chen,
Director, Division of Grants Management.
[FR Doc. E8-17336 Filed 7-28-08; 8:45 am]
BILLING CODE 4162-20-P